| Reparixin in COVID-19 Pneumonia - Efficacy and Safety (NCT04794803) | Dompé Farmaceutici S.p.A | 2020-05-05 |
| Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm (NCT04317534) | Greg Durm, MD | 2020-05-05 |
| Asymptomatic COVID-19 Trial (NCT04374552) | Rutgers, The State University of New Jersey | 2020-05-05 |
| Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia (NCT04374565) | University of Virginia | 2020-05-05 |
| Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting (NCT04128501) | M.D. Anderson Cancer Center | 2020-05-05 |
| Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) (NCT04355429) | Assistance Publique - Hôpitaux de Paris | 2020-05-05 |
| A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (NCT04363736) | Hoffmann-La Roche | 2020-05-05 |
| Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer (NCT04248998) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-05-05 |
| Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection (NCT04375098) | Pontificia Universidad Catolica de Chile | 2020-05-04 |
| Low Dose Radiotherapy in COVID-19 Pneumonia (NCT04390412) | Shahid Beheshti University of Medical Sciences | 2020-05-04 |
| Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects (NCT04334460) | Blade Therapeutics | 2020-05-04 |
| Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 (NCT04407182) | Catalysis SL | 2020-05-04 |
| Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position (NCT04213885) | Eye Specialists of Indiana | 2020-05-04 |
| Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) (NCT04435717) | Hospital Universitario Ramon y Cajal | 2020-05-04 |
| Effects of Exercise During the Acute Phase of Burns (NCT04511104) | Universiteit Antwerpen | 2020-05-04 |
| Therapeutic Approaches to Malnutrition Enteropathy (NCT03716115) | Queen Mary University of London | 2020-05-04 |
| Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma (NCT04300244) | Åslaug Helland | 2020-05-04 |
| Convalescent Plasma for Patients With COVID-19 (NCT04385199) | Henry Ford Health System | 2020-05-04 |
| Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients (NCT04223596) | Fundación GECP | 2020-05-04 |
| A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients (NCT04369846) | Xantho Biotechnology Co., LTD | 2020-05-04 |
| Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (NCT04424901) | UConn Health | 2020-05-03 |
| Donated Antibodies Working Against nCoV (NCT04429854) | Universitaire Ziekenhuizen KU Leuven | 2020-05-02 |
| Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs (NCT04461925) | Institute of Cell Therapy | 2020-05-02 |
| Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (NCT04319484) | RenJi Hospital | 2020-05-02 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina (NCT04306237) | Imbria Pharmaceuticals, Inc. | 2020-05-01 |
| Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) (NCT04355143) | University of California, Los Angeles | 2020-05-01 |
| Cataract DME - Peri vs. Intraop (NCT03920878) | Emory University | 2020-05-01 |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) (NCT03829878) | Finch Research and Development LLC. | 2020-05-01 |
| Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 (NCT04393727) | Azienda Ospedaliero, Universitaria Pisana | 2020-05-01 |
| Ivermectin and Nitazoxanide Combination Therapy for COVID-19 (NCT04360356) | Tanta University | 2020-05-01 |
| Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19 (NCT04361318) | Tanta University | 2020-05-01 |
| Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study (NCT04341402) | William N Handelman | 2020-05-01 |
| A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy (NCT02597660) | Hospital for Special Surgery, New York | 2020-05-01 |
| Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes (NCT02532088) | Universiti Sains Malaysia | 2020-05-01 |
| NOGO for an Overactive Bladder (NCT04357223) | SagaNatura | 2020-05-01 |
| Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors (NCT04504942) | CytoDyn, Inc. | 2020-05-01 |
| Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection (NCT04377659) | Memorial Sloan Kettering Cancer Center | 2020-05-01 |
| First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC (NCT04363255) | Taizhou Hospital | 2020-05-01 |
| Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease (NCT03687476) | Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company | 2020-05-01 |
| Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells (NCT04361942) | Red de Terapia Celular | 2020-05-01 |
| The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations (NCT04363840) | Louisiana State University Health Sciences Center in New Orleans | 2020-05-01 |
| Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib (NCT04358562) | Second Affiliated Hospital of Nanchang University | 2020-05-01 |
| Hyperimmune Plasma in Patients With COVID-19 Severe Infection (NCT04385043) | University of Catanzaro | 2020-05-01 |
| Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer (NCT04383977) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-01 |
| Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01） (NCT05167994) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-05-01 |
| Novel Agents for Treatment of High-risk COVID-19 Positive Patients (NCT04374019) | Susanne Arnold | 2020-05-01 |
| Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma (NCT03880279) | Triumvira Immunologics, Inc. | 2020-05-01 |
| Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis (NCT06231433) | IRCCS San Raffaele | 2020-05-01 |
| Study of Anti-CD22 CAR-T Cells Treating Leukemia Children (NCT04340167) | Beijing Boren Hospital | 2020-05-01 |
| Effects of Workstation Ergonomics and Physiotherapy in Cervicogenic Headache. (NCT05827185) | Prince Sattam Bin Abdulaziz University | 2020-05-01 |
| Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T) (NCT04379479) | National Polytechnic Institute, Mexico | 2020-05-01 |
| Microwave Ablation of Primary and Secondary Lung Malignancies (NCT04369872) | University of Calgary | 2020-05-01 |
| RDD1609 as a Treatment for Idiopathic Pruritus Ani (NCT03757403) | RDD Pharma Ltd | 2020-05-01 |
| NeuroCognition After Carotid Recanalization (NCT04219774) | Duke University | 2020-05-01 |
| Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh (NCT04402203) | Bangladesh Medical Research Council (BMRC) | 2020-05-01 |
| The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients (NCT04410341) | Sadat City University | 2020-05-01 |
| Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer (NCT04367025) | Chinese PLA General Hospital | 2020-05-01 |
| Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors (NCT04010071) | Peking Union Medical College Hospital | 2020-05-01 |
| Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19 (NCT04377503) | Hospital Sao Domingos | 2020-05-01 |
| Systemic Chemotherapy Plus PD-1 for Metastasis ICC (NCT04398927) | Sun Yat-sen University | 2020-05-01 |
| Study of Sequential CAR-T Cell Treating Leukemia Children (NCT04340154) | Beijing Boren Hospital | 2020-05-01 |
| Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration (NCT04074408) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-05-01 |
| A Study of N-acetylcysteine in Patients With COVID-19 Infection (NCT04374461) | Memorial Sloan Kettering Cancer Center | 2020-05-01 |
| COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement (NCT03675971) | Unity Health Toronto | 2020-05-01 |
| Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients (NCT05665985) | Universitas Sebelas Maret | 2020-05-01 |
| CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies (NCT04605666) | Nanfang Hospital, Southern Medical University | 2020-05-01 |
| TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas (NCT04335357) | Tiburio Therapeutics | 2020-05-01 |
| Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment (NCT04363216) | Thomas Jefferson University | 2020-05-01 |
| Efficacy and Safety of Itolizumab in COVID-19 Complications (NCT04475588) | Biocon Limited | 2020-05-01 |
| Mesenchymal Stem Cell Infusion for COVID-19 Infection (NCT04444271) | Dr. Zaineb Akram | 2020-05-01 |
| Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 (NCT04416139) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2020-05-01 |
| Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients (NCT04352465) | Azidus Brasil | 2020-05-01 |
| Lorlatinib Combinations in Lung Cancer (NCT04292119) | Massachusetts General Hospital | 2020-05-01 |
| Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients (NCT04370418) | Assiut University | 2020-05-01 |
| Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 (NCT04373044) | University of Southern California | 2020-05-01 |
| Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma (NCT04184518) | Grupo Español Multidisciplinar de Melanoma | 2020-05-01 |
| Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease (NCT04392414) | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 2020-05-01 |
| Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma (NCT04397770) | Peking University Cancer Hospital & Institute | 2020-05-01 |
| The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts. (NCT04400760) | The University of The West Indies | 2020-05-01 |
| Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma (NCT04351308) | Peking University People's Hospital | 2020-05-01 |
| Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (NCT04359537) | Shaheed Zulfiqar Ali Bhutto Medical University | 2020-05-01 |
| ACT-20 in Patients With Severe COVID-19 Pneumonia (NCT04398303) | Aspire Health Science | 2020-05-01 |
| Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer (NCT04355858) | Fudan University | 2020-05-01 |
| Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis (NCT04238923) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2020-05-01 |
| Convalescent Plasma for Patients With COVID-19: A Pilot Study (NCT04332380) | Universidad del Rosario | 2020-05-01 |
| Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women (NCT04354441) | Sir Mortimer B. Davis - Jewish General Hospital | 2020-05-01 |
| Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma. (NCT03758729) | Samsung Medical Center | 2020-05-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection (NCT04374032) | Bosnalijek D.D | 2020-05-01 |
| Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting (NCT04284852) | The University of Hong Kong | 2020-05-01 |
| The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia (NCT04398459) | Institute of Hematology & Blood Diseases Hospital, China | 2020-05-01 |
| Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia (NCT04380376) | Federal State Budgetary Institution, Pulmonology Scientific Research Institute | 2020-04-30 |
| Reduced Intensity Transplantation for Severe Sickle Cell Disease (NCT04362293) | St. Jude Children's Research Hospital | 2020-04-30 |
| A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer (NCT04241276) | Queen Mary University of London | 2020-04-30 |
| FDOPA PET and Nutritional Support in Parkinson's Disease (NCT04459052) | Thomas Jefferson University | 2020-04-30 |
| CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations (NCT04260529) | Cytovation AS | 2020-04-30 |
| Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS (NCT04374149) | Prisma Health-Upstate | 2020-04-30 |
| A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. (NCT04153929) | Boehringer Ingelheim | 2020-04-30 |
| Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (NCT04335136) | Apeiron Biologics | 2020-04-30 |
| Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis (NCT04163419) | Massachusetts General Hospital | 2020-04-30 |
| Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease (NCT04391712) | Lowell General Hospital | 2020-04-30 |